Viewing StudyNCT05167500



Ignite Creation Date: 2024-05-06 @ 5:00 PM
Last Modification Date: 2024-10-26 @ 2:20 PM
Study NCT ID: NCT05167500
Status: COMPLETED
Last Update Posted: 2023-03-30
First Post: 2021-11-09

Brief Title: Efficacy Safety Study of Lorlatinib in ALKROS1 Metastatic NSCLC Patients With Compassionate Use Treatment
Sponsor: Fundación GECP
Organization: Fundación GECP

Conditions & Keywords Data

Conditions:
Name
Metastatic Non Small Cell Lung Cancer
Keywords:
Name View
ROS1 alteration View
Lung Diseases View
Non small cell lung cancer View
Metastatic disease View
Lorlatinib View
ALK alteration View